GUARD MEDICAL
Follow for NPseal: an easy-to-use and cost-effective #NPWT dressing. Our goal is to reduce #SSI and improve patient care
Follow for NPseal: an easy-to-use and cost-effective #NPWT dressing. Our goal is to reduce #SSI and improve patient care
Guard Medical is a health care startup focusing on developing NPseal, an innovative negative pressure wound therapy (NPWT) dressing. The company's mission is to make NPWT more accessible and affordable to reduce surgical site infections (SSI) and enhance patient care. Founded in 2020 and headquartered in the United States, Guard Medical secured a significant $11.00M Series B investment on 05 April 2022 from Bpifrance and MAT INVEST. Guard Medical's NPseal aims to revolutionize the use of NPWT by eliminating the need for batteries and tubes while providing an easy-to-use and cost-effective solution for closed surgical incisions. With a focus on innovation and patient well-being, Guard Medical is positioned to become a key player in advancing medical care and improving patient quality-of-life with smarter healing.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $11.00M | 2 |
|
05 Apr 2022 |
| Series A | $5.00M | - | 29 Jun 2020 |
No recent news or press coverage available for GUARD MEDICAL.
We care about your data, and we'd love to use cookies make your experience better.
